FDA Inspection 1109969 — Stason Pharmaceuticals, Inc.
The FDA completed an inspection of Stason Pharmaceuticals, Inc. on Oct 25, 2019 in Irvine, CA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Oct 25, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Irvine, CA (United States)